← Leaderboards
Maurizio Bocchetta
Loyola University Chicago
$1,786,710
Attributed
$1,786,710
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $310.2K · FY2009–13$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,786,710 · 2
By mechanism
R01$1,490,710 · 1
R21$296,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Loyola University Chicago
Same institution · by research overlap
- Susan G Fisher$2,293,585
- T. Celeste Napier$4,136,781
- Amanda Lee Mickiewicz$502,451
- James J Palacino$20,300
- Brian J Nickoloff$8,337,580
Others in their field
Top investigators on “Acute T Cell Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$62,800,467
- Gregory H Reaman · National Childhood Cancer Foundation$49,683,603
- Markus Mãschen · Yale University$26,028,700
- Iannis Aifantis · New York University School Of Medicine$25,498,123
- Timothy J Ley · Washington University$24,989,734
Research focus
Acute T Cell LeukemiaCisplatinAffectAlzheimer&Apos1-Phosphatidylinositol 3-KinaseAntibodiesAntineoplastic AgentsApoptosisAreaBiologicalBiological PreservationAmyloidCancer BiologyCancer CellCancer EtiologyCancer Stem CellCell DeathCell LineCell NucleusCellsCessation Of LifeChemotherapyCigarette SmokingClinic
Grant awards (7)
Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC$282,852
R01 · FY2013 · CA · contact PI
Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC$300,906
R01 · FY2012 · CA · contact PI
Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC$300,906
R01 · FY2011 · CA · contact PI
Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC$310,213
R01 · FY2010 · CA · contact PI
Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC$295,833
R01 · FY2009 · CA · contact PI
Selection of chemical inhibitors of oncoproteins$148,000
R21 · FY2002 · CA
Selection of chemical inhibitors of oncoproteins$148,000
R21 · FY2001 · CA